1. Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies

   • K. S. Sridhar
   • A. Krishan
   • P. W. Benedetto

   Original Articles Pages: 423 - 430

2. MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients

   • Cheppail Ramachandran
   • Antonieta Sauerteig
   • Awtar Krishan

   Original Articles Pages: 431 - 441

3. Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapy

   • Stefan C. Grant
   • Mark G. Kris
   • Leslie B. Tyson

   Original Articles Pages: 442 - 444

4. Phase II study of NK313 in malignant lymphomas: an NK313 Malignant Lymphoma Study Group trial

   • Takashi Yoshida
   • Makoto Ogawa
   • Tamotsu Matsuda

   Original Articles Pages: 445 - 448

5. Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study

   • Alessandro Olivi
   • Mark Gilbert
   • Henry Brem

   Original Articles Pages: 449 - 454

6. Effect of hyperthermia on the activity of 1-[(4′-hydroxy-2′-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells

   • Tetsuya Kusumoto
   • Yoshihiko Maehara
   • Keizo Sugimachi

   Original Articles Pages: 455 - 458

7. Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma

   • David E. Schteingart
   • Joseph E. Sinsheimer
   • Linda L. Wotring

   Original Articles Pages: 459 - 466

8. Biodistribution and toxicity of photoproducts of merocyanine 540

   • S. Pervaiz
   • M. Battaglino
   • K. S. Gulliya

   Original Articles Pages: 467 - 474

9. Pharmacokinetics of (1R,2R-diaminocyclohexane)oxalatoplatinum(II) in comparison with cisplatin following a single intravenous injection in rabbits

   • Ryoichi Kizu
   • Shin-ichi Higashi
   • Motoichi Miyazaki

   Original Articles Pages: 475 - 480

10. Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

    • Jonathan H. Marsh
    • Willi Kreis
    • Daniel R. Budman

    Original Articles Pages: 481 - 484

11. An in vivo and in vitro trial of aclarubicin in metastatic breast cancer: a novel approach to the study of analogs

    • Ronald B. Natale
    • Robert L. Cody
    • Richard H. Wheeler

    Original Articles Pages: 485 - 488

12. Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: A South-East European Oncology Group study

    • J. Jassem
    • F. Gyergvay
    • S. Eckhardt

    Original Articles Pages: 489 - 494

13. Evidence of an absorption phase after short intravenous suramin infusions

    • Paul R. Hutson
    • Kendra Tutsch
    • George Wilding

    Original Articles Pages: 495 - 499

14. Letter in response to paper by Abratt et al., Cancer Chemother Pharmacol (1992) 30: 495

    • Suresh Senan
    • Raymond P. Abratt

    Letter/Reply to the Editors Pages: 500 - 501